Ipilimumab vs Topiramate
Ipilimumab vs Topiramate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Topiramate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Topiramate: Multiple mechanisms: Na+ channel block, GABA enhancement, glutamate inhibition.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Topiramate — 21 hours.
Chemical Properties
Molecular Formula: Topiramate — C12H21NO8S.
Molecular Weight: Topiramate — 339.3630 g/mol.
Type: Ipilimumab — Antibody; Topiramate — Small molecule.